
From: BMT Newsletter, November 1994 Issue # 26 - BMTs for Acute Lymphocytic
Leukemia. Reprinted by NYSERNet with Permission from BMT Newsletter
Special Thanks...
to our corporate sponsors whose support helps make publication of BMT
newsletter possible:
- Armour Pharmaceuticals
- Immunex Corporation
- Sandoz Oncology, Sandoz Pharmaceuticals Corp.
Special thanks to the following BMT centers for their recent contribution to
BMT Newsletter:
- All Children's Hospital, St. Petersburg FL
- Canterbury Health Ltd., Christchurch, New Zealand
- Cook Fort Worth Children's Medical Center, Ft Worth TX
- Dartmouth Hitchcock Medical Center, Lebanon NH
- Holy Cross Hospital, Silver Spring MD
- Mayo Clinic, Rochester MN
- Oxford Medical Group, White Plains NY
- Presbyterian Healthcare Services, Albuquerque NM
- St. Joseph Medical Center, Tacoma WA
- University of Arizona Cancer Center, Tucson AZ
- University of North Carolina Medical Center, Chapel Hill NC
- University of Pittsburgh Medical Center, Pittsburgh PA
- University of Texas Health Science Center, San Antonio TX
- Westlake Comprehensive Cancer Center, Westlake Village CA
- York Cancer Center, York PA
BMT Newsletter is written and published by Susan Stewart, a former BMT
patient. Medical advisors for this issue were:
- Nelson J Chao MD, Stanford University
- Medical Center, Stanford CA
- Stephen J Forman, City of Hope National Medical Center, Duarte CA
- Morris Kletzel MD, Children's Memorial Hospital, Chicago IL
- Norma K C Ramsay MD, University of Minnesota Medical School, Minneapolis MN
- Jerome Ritz MD, Dana Farber Cancer Institute, Boston MA
BMT Newsletter is published six times annually. To add your name to the
mailing list phone 847.433.3313 or write BMT Newsletter, 2900 Skokie Valley
Road, Highland Park IL 60035. Contributions to BMT Newsletter are
tax-deductible. (c) 1994.
BMT Newsletter 2900 Skokie Valley Road, Highland Park, Illinois 60035
847.433.3313
The electronic version of this document was created by
NYSERNet, Inc. through a grant funded by the
New York State Science and Technology Foundation as part of the
Breast Cancer Information
Clearinghouse.